Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALATIO: Short vs Long Antibiotic Therapy for Orthopedic Infections
NCT05499481Phase 3Completed
- Sponsor
- University Hospital Balgrist
- Start
- Sep 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in orthopedic implant infection (OII) (2 arms), sponsored by University Hospital Balgrist. Primary endpoints: Clinical remission related to the duration of total, postdebridement, antibiotic use at 1 year and Microbiological recurrence in relation to the total, postdebridement, antibiotic use at 1 year. Started Sep 2022; status: completed.
02
Conditions
orthopedic implant infection (OII)
Beyond the preview
Go deeper on NCT05499481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05499481.